Skip to main content
Michael Rivner, MD, Neurology, Macon, GA

MichaelRivnerMD

Neurology Macon, GA

Neuromuscular Medicine, Neurophysiology, Pain Medicine

Charbonnier Professor of Neurology Georgia Health Sciences University

Dr. Rivner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rivner's full profile

Already have an account?

  • Office

    3351 Northside Dr
    Macon, GA 31210
    Phone+1 478-201-6629
    Fax+1 706-721-8701

Education & Training

  • Medical College of Georgia
    Medical College of GeorgiaFellowship, Pain Medicine, 1982 - 1983
  • Medical College of Georgia
    Medical College of GeorgiaResidency, Neurology, 1978 - 1982
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1978

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 1979 - 2025
  • SC State Medical License
    SC State Medical License 1980 - 2025
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis  
    Brian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology

Press Mentions

  • 'This Is Horrible': Future of Central and South Georgia's Only Clinic for ALS Patients Uncertain
    'This Is Horrible': Future of Central and South Georgia's Only Clinic for ALS Patients UncertainOctober 26th, 2022
  • Augusta Clinic, MCG Student Focus on Patient, Family in Treatment of ALS
    Augusta Clinic, MCG Student Focus on Patient, Family in Treatment of ALSMay 21st, 2021
  • 1st Patient Enrolled in Phase 2a Trial Testing AT-1501 in ALS
    1st Patient Enrolled in Phase 2a Trial Testing AT-1501 in ALSNovember 4th, 2020
  • Join now to see all